The total return over the past 12 months is +72.10% vs. +16.94% for the S&P 500. So far it's up +65.49% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +72.10% | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | +72.10% | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | +176.49% | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
CG Oncology Inc. (CGON)
| Year | Start price | End price | CGON Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $41.52 | $68.71 | +65.49% | +14.51% | +50.98% |
| 2025 | $28.68 | $41.52 | +44.77% | +17.72% | +27.05% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
